Accordingly, people in whom T2D had led to HITI are likely to (i) have higher levels of IL-6 and hs-CRP and (ii) show particular therapeutic benefit to IL-6 inhibition. The gene discussed is IL6; the disease is type 2 diabetes mellitus.